CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.
September 8th 2025
The FDA has granted orphan drug designation to the investigational therapy BA-101 for the treatment of patients with glioblastoma.
FDA Fast Tracks Investigational Drug for the Treatment of Recurrent Brain Cancer
July 15th 2022The safety, optimal dosage and efficacy of the investigational drug is currently being evaluated in a first-in-human trial in patients with recurrent high-grade glioblastoma, a type of spinal cord and brain cancer.